Meghalayan Medical Drugs And Services Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 26-12-2024
- Paid Up Capital ₹ 0.50 M
as on 26-12-2024
- Company Age 2 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.19 Cr
as on 26-12-2024
About Meghalayan Medical Drugs And Services
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹6.19 Cr.
Sampath Pamu, Janupribalas Momin, Wolker Kharlukhi, and Five other members serve as directors at the Company.
- CIN/LLPIN
U85300ML2022SGC013895
- Company No.
013895
- Company Classification
Public Limited State Government Company
- Incorporation Date
13 Nov 2022
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Shillong
Industry
Company Details
- Location
Khasi Hills, Meghalaya, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Meghalayan Medical Drugs And Services?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ramkumar Sathurappan  | Managing Director | 13-Nov-2022 | Current |
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sampath Pamu | Director | 13-Nov-2022 | Current |
| Janupribalas Momin | Nominee Director | 22-May-2024 | Current |
| Wolker Kharlukhi | Nominee Director | 01-Mar-2024 | Current |
| Fairnolyn Kharshiing | Nominee Director | 01-Mar-2024 | Current |
| Rilynti Lyngdoh | Nominee Director | 11-Sep-2023 | Current |
| Lumlang Thangkhiew | Nominee Director | 01-Sep-2023 | Current |
Financial Performance of Meghalayan Medical Drugs And Services.
Enhance accessibility to Meghalayan Medical Drugs And Services's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Meghalayan Medical Drugs And Services?
In 2023, Meghalayan Medical Drugs And Services had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Livelihood Improvement Finance Company Of MeghalayaActive 15 years 7 monthsSampath Pamu is a mutual person
- Meghalaya Infrastructure Development And Finance Corporation LimitedActive 10 years 4 months
Sampath Pamu is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Sep 2024 | ₹6.19 Cr | Open |
How Many Employees Work at Meghalayan Medical Drugs And Services?
Meghalayan Medical Drugs And Services has a workforce of 0 employees as of Oct 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Meghalayan Medical Drugs And Services, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Meghalayan Medical Drugs And Services's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
